Evidence map›Paper›PMID 18055487›Full record

ArticleBMJ (Clinical research ed.)2007

New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study.

Lourdes Mahilum-Tapay, Vivian Laitila, James J Wawrzyniak, Helen H Lee, Sarah Alexander, Catherine Ison, Alison Swain, Penelope Barber, Ines Ushiro-Lumb, Beng T Goh

Registry-linked trialOpen access · bronzeAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03767231 (Emergency Department Patient's Perceptions and Acceptability Toward a Novel Point-of-Care Hepatitis C Virus Viral Load Testing), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03767231 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Emergency Department Patient's Perceptions and Acceptability Toward a Novel Point-of-Care Hepatitis C Virus Viral Load Testing

TypeinterventionalSponsorJohns Hopkins UniversityRan2026 to 2027Enrolled200ConditionsHepatitis CArmsXpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid)
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Light Forge: A Microfluidic DNA Melting-based Tuberculosis Test.The journal of applied laboratory medicine · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Lourdes Mahilum-TapayDiagnostics for the Real World (Europe) Ltd, Cambridge Science Park, Cambridge CB4 0WG.
Vivian Laitila
James J Wawrzyniak
Helen H Lee
Sarah Alexander
Catherine Ison
Alison Swain
Penelope Barber
Ines Ushiro-Lumb
Beng T Goh
Barts Health NHS Trust · GBHealth Protection Agency · MVUniversity of Cambridge · GBDiagnostics for the Real World (United States) · USVitenparken · NO

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveTo evaluate the performance of a new Chlamydia Rapid Test with vaginal swab specimens as a potential tool for chlamydia diagnosis and screening.

designPerformance evaluation study. Settings A young people's sexual health centre (site 1) and two genitourinary medicine clinics (sites 2 and 3) in the United Kingdom.

participants1349 women aged between 16 and 54 attending one of the three clinics.

main outcome measuresSensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test versus polymerase chain reaction and strand displacement amplification assays; correlation between the Chlamydia Rapid Test visual signal and organism load; acceptability to participants of self collected vaginal swabs as the specimen type for Chlamydia testing.

resultsPolymerase chain reaction positivity rates for Chlamydia trachomatis infection were 8.4% (56/663) at site 1, 9.4% (36/385) at site 2, and 6.0% (18/301) at site 3. Compared with polymerase chain reaction assay, the resolved sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test were 83.5% (91/109), 98.9% (1224/1238), 86.7% (91/105), and 98.6% (1224/1242). Compared with strand displacement amplification assay, sensitivity and specificity of the Chlamydia Rapid Test were 81.6% (40/49) and 98.3% (578/588). Organism load of self collected vaginal swabs ranged from 5.97x10(2) to 1.09x10(9) Chlamydia plasmids per swab, which correlated well with the Chlamydia Rapid Test's visual signal (r=0.6435, P<0.0001). Most (95.9%) surveyed participants felt comfortable about collecting their own swabs.

conclusionsThe performance of the Chlamydia Rapid Test with self collected vaginal swabs indicates that it would be an effective same day diagnostic and screening tool for Chlamydia infection in women. The availability of Chlamydia Rapid Test results within 30 minutes allows for immediate treatment and contact tracing, potentially reducing the risks of persistent infection and onward transmission. It could also provide a simple and reliable alternative to nucleic acid amplification tests in chlamydia screening programmes.

Indexed as

AdolescentAdultChlamydia InfectionsDNA, BacterialFemaleHumansMicrobiological TechniquesMiddle AgedPatient SatisfactionPoint-of-Care SystemsPolymerase Chain ReactionSpecimen HandlingVaginal SmearsDNA, Bacterial

Identifiers

PMID18055487
PMCPMC2128659
OpenAlexW1976507448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.